AXGN Axogen
Axogen (AXGN) is the leading company focused specifically on the science, development, and commercialization of technologies for peripheral nerve regeneration and repair. Axogen employees are passionate about helping to restore peripheral nerve function and quality of life to patients with physical damage or transection to peripheral nerves by providing innovative, clinically proven, and economically effective repair solutions for surgeons and health care providers. Peripheral nerves provide the pathways for both motor and sensory signals throughout the body. Every day, people suffer traumatic injuries or undergo surgical procedures that impact the function of their peripheral nerves. Physical damage to a peripheral nerve, or the inability to properly reconnect peripheral nerves, can result in the loss of muscle or organ function, the loss of sensory feeling, or the initiation of pain.
Company profile
Ticker
AXGN
Exchange
Website
CEO
Karen L. Zaderej
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
Medtronic • Varian Medical Systems • Conmed • Masimo • Natus Medical • LivaNova • Outset Medical • Fonar • Cutera • Inmode ...
Former names
LECTEC CORP /MN/
SEC CIK
Corporate docs
IRS number
411301878
AXGN stock data
()
News
The Week Ahead In Biotech (Aug. 1-7): Biopharma Earnings Pick Up Pace, Eton Awaits FDA Decision, Focus On Pending Clinical Readouts and IPOs
1 Aug 21
Axogen To Stop Commercial Sales Of Avive Soft Tissue Membrane Pending Discussions With FDA
18 May 21
Stocks That Hit 52-Week Highs On Friday
7 May 21
72 Biggest Movers From Yesterday
7 May 21
Canaccord Genuity Maintains Hold on Axogen, Raises Price Target to $24
6 May 21
Investment data
Securities sold
Number of investors
Calendar
6 May 21
2 Aug 21
31 Dec 21
Financial summary
Quarter (USD) |
Mar 21 | Dec 20 | Sep 20 | Jun 20 | |
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Operating income | |||||
| Operating margin | |||||
| Net income | |||||
| Net profit margin | |||||
| Cash on hand | |||||
| Change in cash | |||||
| Diluted EPS |
Annual (USD) |
Dec 20 | Dec 19 | Dec 18 | Dec 17 | |
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Operating income | |||||
| Operating margin | |||||
| Net income | |||||
| Net profit margin | |||||
| Cash on hand | |||||
| Change in cash | |||||
| Diluted EPS |
Financial data from Axogen earnings reports.
| Cash burn rate (estimated) | Burn method: Change in cash | Burn method: Operating income/loss | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
|---|---|---|---|---|---|---|
| Cash on hand (at last report) | 46.18M | 46.18M | 46.18M | 46.18M | 46.18M | 46.18M |
| Cash burn (monthly) | 3.14M | (positive/no burn) | 2.07M | 1.74M | 3.61M | 1.03M |
| Cash used (since last report) | 12.84M | n/a | 8.47M | 7.11M | 14.73M | 4.22M |
| Cash remaining | 33.33M | n/a | 37.71M | 39.06M | 31.44M | 41.96M |
| Runway (months of cash) | 10.6 | n/a | 18.2 | 22.4 | 8.7 | 40.6 |
Recent insider trades
| Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
|---|---|---|---|---|---|---|---|---|---|---|
| 21 Jul 21 | Donovan Michael Patrick | Common Stock | Sell | Dispose S | No | Yes | 20.04 | 1,935 | 38.78K | 40,839 |
| 20 Jul 21 | Martinez Maria D. | Common Stock | Payment of exercise | Dispose F | No | No | 19.2 | 637 | 12.23K | 4,867 |
| 20 Jul 21 | Friedman Mark Louis | Common Stock | Payment of exercise | Dispose F | No | No | 19.2 | 637 | 12.23K | 16,308 |
| 19 Jul 21 | Johnson John | Stock Options Common Stock | Grant | Aquire A | No | No | 19.44 | 27,638 | 537.28K | 27,638 |
| 19 Jul 21 | Martinez Maria D. | Common Stock | Grant | Aquire A | No | No | 0 | 2,572 | 0 | 5,504 |
| 19 Jul 21 | Friedman Mark Louis | Common Stock | Grant | Aquire A | No | No | 0 | 2,572 | 0 | 16,945 |
Institutional ownership Q1 2021
Data for the last complete 13F reporting period. To see the most recent changes to ownership, click the ownership history button above.
80.7% owned by funds/institutions
13F holders |
Current |
|---|---|
| Total holders | 122 |
| Opened positions | 14 |
| Closed positions | 14 |
| Increased positions | 38 |
| Reduced positions | 49 |
13F shares |
Current |
|---|---|
| Total value | 761.47M |
| Total shares | 33.09M |
| Total puts | 75K |
| Total calls | 23.4K |
| Total put/call ratio | 3.2 |
Largest owners |
Shares | Value |
|---|---|---|
| ArrowMark Colorado | 5.9M | $119.45M |
| BLK Blackrock | 3.03M | $61.35M |
| First Light Asset Management | 2.56M | $51.81M |
| EW Healthcare Partners | 1.98M | $35.48M |
| Vanguard | 1.93M | $39.19M |
| Essex Woodlands Management | 1.76M | $35.65M |
| William Blair Investment Management | 1.47M | $29.68M |
| JHG Janus Henderson | 1.37M | $27.8M |
| Baillie Gifford & Co | 1.17M | $23.74M |
| BAC Bank Of America | 1.03M | $20.9M |
Financial report summary
?Content analysis
?
| Positive | ||
| Negative | ||
| Uncertain | ||
| Constraining | ||
| Legalese | ||
| Litigous | ||
| Readability |
H.S. sophomore Avg
|
|
New words:
algorithm, assume, Bussey, cease, Concentration, conversion, Director, doubtful, Factor, FDIC, flat, floor, grow, history, internationally, irrevocable, issuable, letter, metric, Minn, payout, Qualitative, Quantitative, reconciliation, reinitiated, Rethink, sixty, standby, strength, subsidiary, symposium, target, targeted, tool, uncollectible, usable
Removed:
adapted, adding, Administration, advance, adversely, Alachua, alleged, applied, assessing, ASU, border, capitalization, capitalizing, carefully, CCA, CDC, CECL, chain, Civil, cleaning, cloud, collection, commodity, communicate, compensatory, complied, composition, computation, computing, conference, continually, continuing, correctly, County, create, currency, declared, decline, defer, deferment, delay, denominated, Department, detailed, deterioration, Detroit, developing, discontinued, discretionary, Disease, disinfecting, distancing, domestic, economy, eliminating, enter, entering, Euro, evaluate, exempt, existing, explained, exposed, exposure, FASB, Filing, Fire, firm, flexibility, foreign, freeze, fund, guidance, hiring, home, hosted, impacting, impairment, implementation, important, incidence, industry, Inflation, initiative, injury, intent, interaction, invoiced, language, layoff, led, Leerink, lifetime, lifted, limit, manage, mandate, manner, member, minimal, Minnesota, mitigate, mitigation, MN, modifying, month, objective, obtaining, occurring, operate, order, original, originated, outbreak, patient, Paycheck, perform, personal, personnel, Police, post, PPP, prepare, preserve, preserving, priority, production, project, prospective, quantified, RANGER, reallocate, Recently, recommended, RECON, record, recovery, reduced, referenced, referred, reimbursement, relate, reliably, remain, remotely, REPOSE, request, requesting, rescission, resolve, restrict, Retirement, rotational, RSU, safety, salaried, SBA, scheduled, seeking, selected, separation, serve, shut, significantly, situation, slightly, social, software, spread, stabilize, strategy, surrendered, suspended, suspension, sweep, thousand, Topic, transmission, treat, turn, ultimate, Underwriting, upfront, vendor, wearing, weekly, withhold, work, workforce, World
Financial reports
10-Q
2021 Q1
Quarterly report
6 May 21
10-K
2020 FY
Annual report
1 Mar 21
10-Q
2020 Q3
Quarterly report
30 Oct 20
10-Q
2020 Q2
Quarterly report
9 Aug 20
10-K/A
2019 FY
Annual report (amended)
12 Jun 20
10-Q
2020 Q1
Quarterly report
6 May 20
10-K
2019 FY
Annual report
24 Feb 20
10-Q
2019 Q3
Quarterly report
6 Nov 19
10-Q
2019 Q2
Quarterly report
6 Aug 19
10-Q
2019 Q1
Quarterly report
8 May 19
Current reports
8-K
Axogen, Inc. Appoints John H. Johnson to Board of Directors
19 Jul 21
8-K
Entry into a Material Definitive Agreement
16 Jul 21
8-K
Regulation FD Disclosure
17 May 21
8-K
Submission of Matters to a Vote of Security Holders
10 May 21
8-K
Axogen, Inc. Reports 2021 First Quarter Financial Results
5 May 21
8-K
Entry into a Material Definitive Agreement
26 Feb 21
8-K
Axogen, Inc. Reports 2020 Fourth Quarter
22 Feb 21
8-K
Regulation FD Disclosure
18 Feb 21
8-K
Other Events
14 Jan 21
8-K
Axogen Reports Preliminary Unaudited Revenue
11 Jan 21
Registration and prospectus
S-8
Registration of securities for employees
11 May 21
S-3ASR
Automatic shelf registration
6 May 21
424B3
Prospectus supplement
8 Jan 21
S-8 POS
Registration of securities for employees (post-effective amendment)
22 Aug 19
S-8 POS
Registration of securities for employees (post-effective amendment)
22 Aug 19
S-8 POS
Registration of securities for employees (post-effective amendment)
22 Aug 19
S-8 POS
Registration of securities for employees (post-effective amendment)
22 Aug 19
S-8 POS
Registration of securities for employees (post-effective amendment)
22 Aug 19
S-8
Registration of securities for employees
22 Aug 19
S-8
Registration of securities for employees
20 Mar 19
Proxies
DEF 14A
Definitive proxy
31 Mar 21
DEF 14A
Definitive proxy
17 Apr 20
DEF 14A
Definitive proxy
27 Jun 19
DEFA14A
Additional proxy soliciting materials
29 Mar 18
DEFA14A
Additional proxy soliciting materials
29 Mar 18
DEF 14A
Definitive proxy
28 Mar 18
PRE 14A
Preliminary proxy
14 Mar 18
DEF 14A
Definitive proxy
6 Apr 17
DEF 14A
Definitive proxy
7 Apr 16
DEF 14A
Definitive proxy
14 Apr 15
Other
UPLOAD
Letter from SEC
15 Jun 20
CORRESP
Correspondence with SEC
21 May 20
UPLOAD
Letter from SEC
26 Apr 20
CT ORDER
Confidential treatment order
5 Mar 19
CT ORDER
Confidential treatment order
29 Mar 18
EFFECT
Notice of effectiveness
10 Oct 17
CORRESP
Correspondence with SEC
5 Oct 17
UPLOAD
Letter from SEC
3 Oct 17
CT ORDER
Confidential treatment order
26 Mar 17
EFFECT
Notice of effectiveness
10 Dec 15
Ownership
4
Axogen / Michael Patrick Donovan ownership change
23 Jul 21
4
Axogen / Erick Wayne DeVinney ownership change
21 Jul 21
4
Axogen / Michael Patrick Donovan ownership change
21 Jul 21
4
Axogen / Karen L. Zaderej ownership change
21 Jul 21
4
Axogen / Eric Sandberg ownership change
21 Jul 21
4
Axogen / Angelo Scopelianos ownership change
21 Jul 21
4
Axogen / PETER J MARIANI ownership change
21 Jul 21
4
Axogen / Isabelle Billet ownership change
21 Jul 21
4
Axogen / MARIA D. MARTINEZ ownership change
21 Jul 21
4
Axogen / Mark Louis Friedman ownership change
21 Jul 21
Patents
APP
Utility
Devices and Methods for Protecting Against Neuromas
24 Jun 21
The subject invention provides devices and methods for alleviating discomfort associated with neuroma formation.
APP
Utility
Devices and Methods for Protecting Against Neuromas
3 Jun 21
The subject invention provides devices and methods for alleviating discomfort associated with neuroma formation.
GRANT
Utility
Materials and methods for protecting against neuromas
23 Mar 21
The subject invention provides devices and methods for alleviating discomfort associated with neuroma formation.
APP
Utility
Tissue-processing Container for Automated Processing of Tissue, Methods of Use Thereof, and Systems Comprising the Same
18 Mar 21
Tissue-processing containers are disclosed for facilitating multistep processing of tissue.
GRANT
Utility
Implant devices with a pre-set pulley system
16 Mar 21
The problem of positioning one or more nerve ends inside a sheathing implant is solved by the use of a pulley and cinching systems that pull a nerve end into an implant and that can adjust the diameter of an implant to conform the implant to the diameter of the nerve, respectively.
Transcripts
2021 Q1
Earnings call transcript
9 May 21
2020 Q4
Earnings call transcript
23 Feb 21
2020 Q3
Earnings call transcript
1 Nov 20
2020 Q2
Earnings call transcript
5 Aug 20
2020 Q1
Earnings call transcript
8 May 20
2019 Q4
Earnings call transcript
24 Feb 20
2019 Q3
Earnings call transcript
6 Nov 19
2019 Q2
Earnings call transcript
6 Aug 19
2019 Q1
Earnings call transcript
8 May 19
2018 Q4
Earnings call transcript
26 Feb 19
Reddit threads
Daily Discussion Thread - August 2nd, 2021
2 Aug 21
Daily Discussion Thread - May 5th, 2021
5 May 21
Daily Discussion Thread - May 4th, 2021
4 May 21
Daily Discussion Thread - May 3rd, 2021
3 May 21
Daily Discussion Thread - February 22nd, 2021
22 Feb 21
Daily Discussion Thread - February 19th, 2021
19 Feb 21
Daily Discussion Thread - October 29th, 2020
29 Oct 20
Daily Discussion Thread - October 28th, 2020
28 Oct 20